About US
Contact us
-
ScinoPharm and CVie to develop new heart failure treatmentScinoPharm Taiwan, in collaboration with pharmaceutical products manufacturer CVie Therapeutics, has launched a discovery and development collaboration to identify the new generation compound to heart2016/8/9
-
Deals this week: Orgenesis, Advanced Accelerator Applications, Kyowa PharmaceuticalOrgenesis INChas formed a joint venture (JV) with Atvio Biotech to provide gene and cell therapy development services. According to the agreement, Orgenesis and shareholders of Atvio hold a 50-50 par2016/8/8
-
Genetic testing of rare form of tumour can reveal cancer chances in familiesA new study has revealed that genetic testing of patients with a rare form of cancer can pick out genetic errors hidden in their family that increases the risk of a wide range of cancer types. Geneti2016/8/8
-
M&As this week: Teva Pharmaceutical Industries Ltd, Epic Health ServicesTeva Pharmaceutical Industries Ltdhas entered a definitive agreement to acquire Anda Inc. from Allergan plc for a purchase consideration of $500m. According to the agreement, Teva will acquire three2016/8/5
-
Novartis’ LEE011 breast cancer treatment receives FDA Breakthrough Therapy designationThe US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Swiss-based healthcare company Novartis’ LEE011 (ribociclib) in combination with letrozole for the treatment o2016/8/5
-
AstraZeneca's bid to protect Crestor fails as judge refuses to block new genericsThe Crestor generics are coming. AstraZeneca failed its last-ditch attempt to protect the blockbuster brand Tuesday, when a federal judge denied its bid for a restraining order. AstraZeneca had argue2016/8/4
-
FDA panel unanimously backs Valeant's suicide-linked psoriasis med, but serious competition awaitsMembers of an FDA-assembled panel of experts definitely agreed on one thing Tuesday: The benefits of Valeant Pharmaceuticals'psoriasis treatmentbrodalumaboutweigh its risks. But how to manage those ri2016/8/4
-
UK High Court judicial review rules NHS to fund for HIV prevention drugThe UK High Court judicial review has ruled that National Health Service (NHS) England will be responsible for the commissioning of Pre-Exposure Prophylaxis (PrEP) drug, a measure used to prevent HIV2016/8/3
-
AstraZeneca and Chi-Med amend agreement for savolitinib to treat several cancersUK-based pharmaceutical company AstraZeneca and Chinese healthcare group Chi-Med have amended the 2011 worldwide licensing, co-development, and commercialisation agreement for savolitinib to treat a n2016/8/3
-
The Art and Science of Forecasting with Clinical InformaticsThe art and science of forecasting with clinical informatics The pharmaceutical industry continues to strive to improve the quality and efficiency of clinical trials but many challenges remain with2016/8/2